Navigation Links
About 1 baby born each hour addicted to opiate drugs in U.S., U-M study shows
Date:4/30/2012

Ann Arbor, Mich. About one baby is born every hour addicted to opiate drugs in the United States, according to new research from University of Michigan physicians.

In the research published April 30 in the Journal of the American Medical Association, U-M physicians found that diagnosis of neonatal abstinence syndrome, a drug withdrawal syndrome among newborns, almost tripled between 2000 and 2009.

By 2009, the estimated number of newborns with the syndrome was 13,539 or about one baby born each hour, according to the study that U-M researchers believe is the first to assess national trends in neonatal abstinence syndrome and mothers using opiate drugs.

"Recently, the Centers for Disease Control and Prevention released a report which found that over the last decade sales for opiate pain relievers like OxyContin and Vicodin have quadrupled," says Stephen W. Patrick, M.D., M.P.H., M.S., lead author of the study and a fellow in the University of Michigan's Division of Neonatal-Perinatal Medicine.

"Although our study was not able to distinguish the exact opiate used during pregnancy, we do know that the overall use of this class of drugs grew by 5-fold over the last decade and this appears to correspond with much higher rates of withdrawal in their infants."

Patrick, a Robert Wood Johnson Clinical Scholar at the University of Michigan, says multiple factors are likely to blame for the dramatic spike in use of opiate pain relievers, from their potential overuse for chronic pain to illegal sales of these drugs on the street. Overall, the U-M study showed that the number of mothers using opiate drugs increased five times over the last decade.

"Opiate use in our country is becoming an epidemic. Too often our health system reacts to problems; instead, we must address opiate use as a public health issue. To do this, we must limit opiate pain reliever use through healthcare provider education and statewide systems that watch for abuses, like people going to multiple doctors to get opiate prescriptions," Patrick says.

Neonatal abstinence syndrome causes a wide array of symptoms including increased irritability, hypertonia, or heightened muscle tone, tremors, feeding intolerance, seizures, and respiratory distress. In addition, babies with the syndrome are more likely to be born with a low birthweight.

"You can often stand in the hallway and know which babies are experiencing withdrawal. They are irritable, their cries are different, and they appear uncomfortable," Patrick says.

The majority of the mothers of babies born with the syndrome were covered by Medicaid for health care costs. The average hospital bill for babies with the syndrome increased from $39,400 in 2000 to $53,400 in 2009, a 35 percent increase. By 2009, 77.6 percent of charges for babies with the syndrome were charged to Medicaid.

In Florida, where opiate pain reliever death now accounts for four times the number of deaths as illicit drugs, the number of newborns diagnosed with the syndrome has increase five-fold in the last six years. The Florida state House and Senate recently passed legislation to form a task force to evaluate the issue.

"Given that newborns with neonatal abstinence syndrome experience longer, often medically complex and costly initial hospitalizations, this study highlights the need for increased public health measures to reduce the number of babies exposed to opiate drugs," says Matthew M. Davis, M.D., M.A.P.P., associate professor in the Child Health Evaluation and Research Unit at the U-M Medical School, and associate professor of Public Policy at the Gerald R. Ford School of Public Policy. Davis is senior author on the paper and co-director of the Robert Wood Johnson Clinical Scholar Program at U-M.

"We hope that state leaders will call for more research into the data we've provided because the majority of hospital expenditures for this condition are shouldered by state Medicaid programs."


'/>"/>

Contact: Mary F. Masson
mfmasson@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert

Related medicine news :

1. Moffitt researchers find adolescents with cancer concerned about their future reproductive health
2. Adjusting Your Attitude About Chronic Pain May Help You Sleep
3. Concerns about MRSA for expectant mothers may be unfounded
4. Stress about wifes breast cancer can harm a mans health
5. What can Hollywood teach us about our planet?
6. NJIT author to speak at UNC about hemophilia
7. Worries About Colonoscopy Unfounded: Study
8. Meeting to outline effective education about aging as Americas senior population grows
9. Many Breast Cancer Patients Uninformed About Options: Study
10. More Known About Proteins That Cause Autoimmune Diseases
11. Educating women about heart attacks could save lives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and ... women in the world, and the most handsome men, look naturally attractive. Plastic ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... SYDNEY , June 26, 2016 One of ... , has announced the formation of a new biotechnology company, Noxopharm ... raise $6m in an IPO and to list on the ASX. ... drug candidate, NOX66, ready to enter a Phase 1 clinical study ... been designed to address one of the biggest problems facing cancer ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: